Home Tags Observations
Biocon stated that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for the post...
Cadila Healthcare Ltd announced that US Food and Drug Administration (FDA) issued Form 483 with zero observations to the company's Baddi unit.
NEW DELHI: JB Chemicals and Pharmaceuticals said its Gujarat unit has passed the US health regulator's periodical inspection with one minor procedural observation.
Divis’s Laboratories has received zero Form 483 observations from US Food and Drug Administration (FDA) for Andhra Pradesh facility.